B1-04: DN-101-004: a multicenter, open label, dose ranging study of DN-101 (ASENTAR”) and docetaxel in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) after platinum-based chemotherapy
West, Howard, Reyno, Leonard, Lee, Stella, Fehrenbacher, Louis, Cohn, Allen L., Hopkins, Judith O., Irwin, David H., Smith, David A., Boyd, Thomas E., Olsen, Mark R.Volume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283142.45552.ce
Date:
August, 2007
File:
PDF, 165 KB
english, 2007